IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
Clinical trial NCT06049810 · COMPLETED
Trial details
- NCT number
- NCT06049810
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-10
- Primary completion
- 2025-04-29
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.